Standout Papers

<sup>68</sup>Ga- and <sup>177</sup>Lu-Labeled PSMA I&amp;T: Optimization of a PSMA-Targeted Theranos... 2015 2026 2018 2022 408
  1. 68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies (2015)
    Martina Weineisen, Margret Schottelius et al. Journal of Nuclear Medicine

Immediate Impact

76 standout
Sub-graph 1 of 21

Citing Papers

Radiopharmaceuticals and their applications in medicine
2025 Standout
An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
15 intermediate papers

Works of Seval Beykan being referenced

Safety, Biodistribution, and Radiation Dosimetry of 68Ga-OPS202 in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase I Imaging Study
2017
68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies
2015 Standout
and 3 more

Author Peers

Author Last Decade Papers Cites
Seval Beykan 615 317 497 13 821
Astrid Gosewisch 538 186 387 20 696
M. Stefanova 499 289 474 7 705
Marcus Bronzel 796 275 655 9 893
Sandra Rosenbaum‐Krumme 511 131 255 23 759
Thomas Armor 445 185 397 14 661
Michael Garkavij 540 311 348 23 717
Monica Celli 526 182 582 30 873
Irina Velikyan 709 404 221 28 943
D. W. Mccarthy 519 182 180 8 687
Alexander Wurzer 481 222 434 30 686

All Works

Loading papers...

Rankless by CCL
2026